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Highly influential recommendations published in 2011 for the classification of the primary progressive aphasias
(PPA) distinguished three subtypes: the semantic variant, the nonfluent/agrammatic variant, and the logopenic
variant. We review empirical evidence published after 2011 that bears relevance to the validity of the recommended
classification scheme. The studies that we review principally rely on monocentric, memory clinic-based consecutive
series of PPA patients. We review whether a data-driven analysis of neurolinguistic test scores confirms the subtyping
that was based on expert consensus, whether the 2011 subtyping covers the diversity of PPA in a comprehensive
manner, and whether the proposed subgroups differ along dimensions that are not explicitly part of the defining
criteria, such as diffusion tractography. Data-driven mathematical analyses of neurolinguistic data in PPA broadly
confirm the presence of separate clusters corresponding to the subtypes but also leave 15–30 % unclassified. A
comprehensive description of PPA requires the addition of the mixed variant as a fourth subtype and needs to leave
room for cases fulfilling the criteria for a root diagnosis of PPA but not those of any of the three subtypes. Finally, given
the limited predictive value of the clinical phenotype for the underlying neuropathology, biomarkers of the underlying
pathology are likely of clinical utility in PPA.Background
Consensus recommendations for the classification of
primary progressive aphasia were published in 2011 [1],
partly motivated by the need to consolidate the logope-
nic variant (LV) [2, 3] as a third subtype in addition to
the nonfluent/agrammatic variant (NFV) [4] and the se-
mantic variant (SV). The latter is also known as seman-
tic dementia [5]. The LV is associated with substantially
higher probability of Alzheimer’s disease (AD) compared
with the other two subtypes—hence its clinical relevance
[2, 3]. We describe the principles of the PPA classifica-
tion scheme and review evidence that appeared after the
recommendations were published and that bears on the
validity of this classification scheme and may also point
to possible ways in which the classification scheme could
be further improved.Correspondence: rik.vandenberghe@uz.kuleuven.ac.be
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Root diagnosis of PPA
The root diagnosis of PPA is based on the objective im-
pairment of language while other cognitive domains (epi-
sodic and topographical memory, constructional praxis,
etc.) are relatively preserved [6]. In the initial disease
stages, impacts on the instrumental activities of daily liv-
ing are entirely attributable to language problems.
Confusion may arise when the root diagnostic criter-
ion is not fulfilled and the subtyping is applied neverthe-
less. In that respect it is of particular importance not to
confuse PPA or any of its subtypes with the left
hemisphere-dominant type of clinically probable AD
with prominent language symptoms, a disease entity that
has been well-known for a long time [7, 8]. In PPA due
to AD, tests of nonverbal domains—for instance, copy of
the overlapping pentagons in the Mini Mental State
examination or ideomotor praxis—should be, by defin-
ition, preserved. On the other hand, in left hemisphere-
dominant clinically probable AD, some other cognitiveicle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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and the PPA root criterion is therefore not fulfilled.
Some clinical features may be particularly discriminative,
such as tests for constructional praxis. Other tests, e.g.,
of verbal episodic memory, may be less reliable as they
will be influenced by the language problems. Neither are
nonverbal episodic memory tests particularly useful in
this respect in our experience as encoding and retrieval
can be affected by the executive dysfunction that can
occur in PPA.
Of patients who fulfilled the root criterion of PPA,
40 % had underlying AD [9]. When AD causes PPA, the
neuropathology is atypical because of the asymmetric,
left hemisphere-dominant distribution of tangles and be-
cause of the higher ratio of neocortical-to-entorhinal
tangles [10].
The logopenic variant
In PPA LV, spontaneous speech is halting and character-
ized by fluency disruptions with incomplete words and
hesitations [11]. Word finding pauses frequently occur
after determiners preceding content words [12]. Gram-
matical processing and motor speech are relatively pre-
served (Fig. 1).
Testing repetition is key to the diagnosis of LV. It is
critical not to rely on a global repetition score but to
take into account the subscores for the different types ofObjective word finding
deficit
ROOT DIAGNOSIS OF PPA
Motor speech deficit or
agrammatism
YES NO
Semantic variant
Nonfluent/agrammatic
variant
YES
Comprehension
impaired
Fig. 1 The basic scheme for PPA classification according to the 2011 recom
criteria for assignment to one of the three subtypes we refer to [1]. Blue, m
used conventional neuropsychological tests; green, subtype. PALPA Psycholimaterials. In LV, the repetition deficit characteristically
affects repetition of longer or complex sentences [13] ra-
ther than single polysyllabic words [13, 14]. This differs
from NFV with speech apraxia where polysyllabic words
will be affected by the motor speech deficit, in particular
when consonant clusters are present. One of the least
specific and most sensitive tests for repetition concerns
the repetition of a string of function words, as in the
MiniMental State Examination test. This item can be
impaired across the entire spectrum of PPA as well as
early in typical AD.
The cognitive deficit underlying the repetition deficit
in LV is most likely a short-term phonological memory
deficit [3]. In LV, the digit span forward is typically de-
creased and this deficit does not extend to short-term
memory for tones or for location [15]. This clearly dif-
fers from SV where digit span forward is often preserved
until late into the disease course.
In a hierarchical clustering analysis of 32 cases with
PPA excluding semantic variant, cases could be grouped
into four clusters [13]. Cluster 1 was characterized by
anomia and deficient repetition of sentences and corre-
sponded to LV PPA, cluster 2 to NFV. Cluster 1a was
further characterized by phonological paraphasias while
cluster 1b lacked these. In cluster 1a all cases were
amyloid-positive on positron emission tomography
(PET) compared with three out of seven cases in clusterPhonological short-term
memory deficit
Logopenic variant
YES
Confrontation naming
Spontaneous speech (Cookie Theft or other)
Spontaneous speech
Polysyllabic word repetition, consonant clusters
Semantic word association test of the PALPA
Word-picture matching 
Repetition of complex sentences
Digit span forwards
Sentence structure during spontaneous speech
Token test; Northwestern Anagram test
mendations. For a more detailed description of positive and negative
ost critical language dimension; gray, some examples of frequently
nguistic Assessment of Language Processing in Aphasia
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tests that best discriminated the amyloid-positive from
the amyloid-negative cases were the presence of phono-
logical paraphasias and the absence of agrammatism and
motor speech disorder. Sentence comprehension and
anomia as such did not have discriminative value within
this non-SV PPA group [13].
This and other studies suggest that the LV encom-
passes at least two subtypes [12–14, 16]: one closely re-
sembles left hemisphere-dominant probable AD and the
other constitutes a more restricted clinical and anatom-
ical phenotype more similar to the original description
[2]. This led Teichmann et al. [12] to propose the term
“logopenic aphasia complex”.
In LV, as the disease progresses [16], language impair-
ment may become more widespread [12], leading to
problems with single word comprehension [16, 17], sin-
gle word repetition, syntax production, and verbal mem-
ory [14]. Non-language cognitive domains may become
affected [14] (for instance, constructional praxis) in such
a way that the pattern blends with left hemisphere-
dominant clinically probable AD [16]. This clinical
course is distinct from that seen in SV where the steady
progression typically remains restricted to language, se-
mantic memory, and executive dysfunction [16]. Other
patients with LV retain a very circumscribed deficit re-
stricted for years to sentence repetition and word finding
difficulties and focal atrophy.
In LV cluster 1a [13], the group-based pattern of atro-
phy, perfusion, and metabolism resembled that seen in
the left hemisphere-dominant, clinically probable AD
cases [12, 14, 18, 19] (Figs. 1 and 2a). In cluster 1b the
damage was more restricted [13] to the temporoparietal
transition zone, as originally described by Gorno-Fig. 2 Metabolic patterns in LV. a Patient with LV PPA and a pattern chara
correspond to cluster 1a. b Patient with LV PPA and a much more restricte
The Z maps are calculated by comparing the individual glucose metabolic
MIMVISTA software (MIM Software Inc., Cleveland, OH, USA), with a range bTempini et al. [2, 3] (Fig. 2b). This probably is the key
region responsible for the repetition deficit in LV and
belongs to the dorsal language pathway [20]. Atrophy in
the temporoparietal transition zone correlates with repe-
tition scores and with gesture imitation scores in PPA
[21]. In LV, the white matter tracts underneath this cor-
tical region, i.e., the temporoparietal portion of the su-
perior longitudinal fascicle, are also damaged [22].
A second, nearby region that has been implicated in
the phonological errors seen in LV is the posterior su-
perior temporal cortex [12, 13]. The posterior superior
temporal sulcus is an area of predilection in typical AD
from the preclinical [23] to the early clinical stage [24]
and activity in this region correlates with word finding
scores in clinically probable AD [24] as well as naming
latency in preclinical AD [23]. Gray matter density in
this region also correlates in LV with scores on lexical
decision for words with a meaning that strongly relates
to sounds (such as “thunder”) [25].
The positive predictive value of the LV phenotype for
a pathological diagnosis of AD is 50–60 % [9, 26, 27],
which is lower than what is found in in vivo amyloid
biomarker studies in LV (60–90 % [12, 28]). In a meta-
analysis of PPA LV series from different centers, the
remaining 38 % were due to Tar DNA binding protein
43 (TDP)-associated frontotemporal lobar degeneration
(FTLD) [26], with 5–10 % caused by tau-associated
FTLD [26]. LV can also be caused by AD combined with
Lewy body pathology [9, 27].
The semantic variant
PPA SV is a distinct disease entity throughout the disease
course clinically, anatomically, and neuropathologically—-
hence the frequently used name “semantic dementia” [5].cteristic of left hemisphere-dominant Alzheimer’s disease. This would
d pattern of hypometabolism. This would correspond to cluster 1b.
pattern to the normal age-matched control database using commercial
etween 50 and 80 years
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prehension deficit and object recognition problems (Fig. 1).
In SV, spontaneous speech is fluent, with proportionally
fewer nouns and open-content words than in any of the
other subtypes and an increase in generic words [11]. As
the disease progresses, spontaneous speech becomes re-
stricted to stereotyped utterances consisting of a handful of
connected words that may persist for several years and also
echolalia. Even in an advanced stage, the clinical neuro-
logical examination often remains relatively intact.
Confrontation naming is often severely impaired, and
more so than in LV at a comparable stage [6, 9]. Naming
errors occur initially, mainly for unfamiliar or atypical
items [29], and consist of semantic paraphasias, general-
izations, omissions, and circumlocutions. Patients may
be able to comprehend the words that they cannot re-
trieve [30], but as the disease advances they may also
not be able to comprehend the word. Object recognition
problems and loss of knowledge of visual features of ob-
jects further contribute to the confrontation naming def-
icit in SV. In the written modality, loss of word meaning
leads to surface dyslexia [31]. Patients may also experi-
ence problems identifying persons (knowledge about in-
dividuals) beyond proper name anomia.Fig. 3 Metabolic patterns. a Typical SV PET pattern. b, c Two PPA cases wit
with posterior inferior temporal and inferior parietal hypometabolism. This
SV. In the right hemisphere, however, the hypometabolism is more pronou
damage progressed in the left hemisphere from posterior to anterior temp
clearly within the typical AD range (Aβ42 = 393 pg/ml and total tau = 458 pThe severity of comportmental and personality
changes may vary in SV. Both anatomically and clinic-
ally, SV can overlap with frontotemporal dementia be-
havioral variant (FTD bv). The relative preponderance of
aphasia versus comportmental disturbances depends on
the direction and degree of the left–right asymmetry in
the anterior temporal cortex [32].
During stages when word comprehension and object
identification are still relatively preserved, SV can resem-
ble LV, but in these circumstances the repetition deficit
for specific types of materials, i.e., complex sentences
with high working memory demands and the digit span
forward, is a discriminative sign in favor of LV. If im-
paired repetition occurs in an early stage of SV, it is
most often restricted to series of function words, a sensi-
tive test for repetition deficit across all three types of
PPA.
SV is characterized by a very distinct pattern of anterior
temporal atrophy and hypometabolism (Figs. 1 and 3).
This may be lateralized to the left or may also affect the
right side. Different regions within the anterior temporal
cortex may contribute different aspects to the clinical syn-
drome of SV. Perirhinal cortex belongs to the region of at-
rophy in semantic dementia [33–35] and scores on testsh a combination of left anterior temporal hypometabolism together
could pose diagnostic problems as there are features of both AD and
nced in posterior than in anterior temporal cortex, suggesting that the
oral cortex. In both cases cerebrospinal fluid AD biomarkers were
g/ml in b; Aβ42 = 525 pg/ml and total tau >1200 in c)
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scores correlate with volume loss in temporopolar cortex
and perirhinal cortex [33, 34]. In healthy individuals func-
tional MRI activity patterns in perirhinal cortex, overlap-
ping with the atrophic regions in SV, reflect the semantic
similarities between written words [36]. In typical SV, the
atrophy may often also impinge on anterior inferior
frontal cortex and orbitofrontal cortex [19], which is con-
nected with the anterior temporal pole through the uncin-
ate fascicle. The uncinate fascicle is damaged in SV
compared with LV, as well as the inferior longitudinal fas-
cicle [22, 37]. The latter may contribute to functional ef-
fects at a distance in the posterior fusiform cortex or the
ventral occipitotemporal transition zone. This may ac-
count for the visuoperceptual identification problems
(structural description system) and the loss of knowledge
of visual features that are an integral part of the clinical
picture in many SV patients, despite the fact that these re-
gions as such are structurally relatively intact [29, 38].
In rare cases, the anterior temporal damage may be part
of a more distributed atrophy and hypometabolism ex-
tending contiguously into more posterior temporal cortex
and even inferior parietal cortex (Fig. 3b, c). Such a pat-
tern then corresponds to the typical SV anterior temporal
region plus the typical AD posterior temporal and inferior
parietal region. Distinguishing between SV and left
hemisphere-dominant clinically probable AD may require
biomarker examination in these circumstances.
In a multicenter series, SV was associated with FTLD-
TDP in 69–83 % of cases [26, 39], usually of type C [9].
AD has been described in up to 25 % of PPA SV cases
[9, 26], although in most series prevalence of AD in SV
is substantially lower (10 %) [40]. In SV due to AD, there
is more entorhinal, hippocampal, parahippocampal, and
temporal neocortical volume loss compared with non-
AD SV [40]. FTLD-tau, principally Pick’s disease, can
also occur as a cause [26, 39].
Nonfluent/agrammatic variant
PPA NFV is characterized by agrammatism and/or
speech apraxia (Fig. 1). Agrammatism refers to patho-
logical changes in the morphology of nouns and verbs,
word order, and argument structure, with a decrease in
mean length of utterance and a decrease in sentence
complexity [11]. For a detailed description of the diag-
nostic features of speech apraxia we refer to Josephs
et al. [41, 42]. Schematically, speech apraxia is diagnosed
based on abnormal duration of voxels and of inter-
segmental intervals (with segments referring to sounds,
syllables, or words), unevenness in loudness and pitch
and abnormalities in intonational stress, and sound dis-
tortions and substitutions, in particular for utterances of
increased length and articulatory complexity [41]. This
leads to phonetic errors. Phonetic errors must bedistinguished from phonological errors which occur in
LV in the context of normal prosody and normal sound
production and from starting errors that are seen in LV.
According to an automated analysis of the speech char-
acteristics in NFV, the changes in relative duration and
intensity of vowels as well as the pauses during reading
are the most distinctive features [43]. Other qualitative
features that may be helpful in the diagnosis of speech
apraxia consist of sound and syllable repetitions, groping
and effortful speech, speech initiation problems, and ab-
normalities in coordination with breathing [41].
Most often agrammatism and motor speech deficits
occur together (9 out of 25 PPA in Mesulam et al. [6]).
More rarely, the motor speech deficit may occur in iso-
lation (1 out of 25 in Mesulam et al. [6]). The latter
phenotype has been termed “progressive apraxia of
speech” [41]. Since the deficit is limited to motor speech
and does not affect language processing strictly speaking,
Josephs et al. [41] have argued that this should be set
apart from PPA. Inversely, agrammatism can also occur
without speech apraxia: a hierarchical clustering analysis
in 32 non-SV PPA patients revealed two clusters corre-
sponding to NFV, one in which motor speech disorder
co-occurred with agrammatism and one with agramma-
tism alone [13]. Phenotypically, therefore, one can dis-
tinguish three further subtypes within NFV PPA,
depending on whether the agrammatism and speech
apraxia occur in isolation or together. Over time the ex-
clusivity may disappear [44].
A conspicuous source of heterogeneity within NFV are
the associated neurological signs and symptoms that
may be present at the initial clinical examination or may
appear over the disease course [44]. These signs may
point to progressive supranuclear palsy (PSP) or cortico-
basal degeneration (CBD) as the underlying cause. In 13
patients with progressive apraxia of speech, five evolved
into a PSP-like syndrome while in the remaining sub-
jects the speech problems continued to be the most
prominent symptom along with progressive extrapyram-
idal signs [44].
In progressive apraxia of speech, FDG-PET mainly re-
veals hypometabolism in superior premotor and supple-
mentary motor areas [44, 45] (Fig. 4). Superior premotor
involvement correlates with the degree of speech apraxia
[45]. As the disease progresses, regions at a distance
may become involved, such as inferior parietal or poster-
ior temporal cortex [19]. In the agrammatic variant a
more distributed network is involved, including pars
orbitalis, triangularis, and opercularis along with super-
ior temporal gyrus and inferior parietal lobule [6, 45].
Therefore, speech apraxia and agrammatism rely on ana-
tomically dissociable mechanisms. Likewise, the white
matter tracts involved differ depending on the degree of
speech apraxia versus agrammatism [22]: speech
Fig. 4 Typical metabolic pattern in NFV showing hypometabolism in inferior frontal, premotor, and supplementary motor cortex
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tract from the inferior frontal gyrus (Brodmann area
(BA) 44) and the anterior insula to premotor (BA6 face/
mouth area) and supplementary motor cortex (the
Aslant tract [46]) as well as connections with putamen
and caudate [47]. Sentence comprehension/production,
on the other hand, correlates with involvement of the
superior longitudinal fascicle and the arcuate fascicle
[11, 47]. The dissociation of white matter tract involve-
ment between speech apraxia and agrammatism is not
absolute: motor speech scores also show some correl-
ation with integrity of SLF and arcuate [48].
In NFV, 50–70 % of patients are neuropathologically
diagnosed as FTLD-tau, corresponding to corticobasal
degeneration, progressive supranuclear palsy or Pick’s
disease [9, 26, 39]. Exclusive or predominant apraxia of
speech predicts a tauopathy rather than a TDP43 protei-
nopathy [27] and may be more frequently associated
with PSP than with CBD [39]. Approximately 20 % of
NFV cases are due to FTLD-TDP, usually of type A [27],
and 12–25 % to AD [9, 26].
Cases who do not fit into any of the three classes
In a monocentric series of 84 PPA patients [49], 31 %
could not be assigned to any of the three subtypes. In
another monocentric retrospective series, this occurred
for 5 out of 30 PPA cases [27]. In a third monocentric
longitudinal PPA series of 46 patients, 41 % did not ful-
fill criteria of any of the three subtypes according to
Sajjadi et al. [50]. In the latter series the proportion of
LV was only 4 % [50], suggesting that the unclassifiables
contained cases that in other series could have beenassigned to LV. Indeed, in a series by Sajjadi et al. [51]
volumetric analysis of 14 unclassified patients revealed
an “LV PPA like” pattern. This led the authors to
conclude that the unclassifiable cases are more likely
“AD-related aphasias.” A case can be unclassifiable be-
cause it is missing some of the positive features that are
necessary for assigning it to one of the three subtypes
proposed by Gorno-Tempini et al. [1]. A case can also
be unclassifiable because positive features belonging
each to different subtypes occur in combination. The
mixed variant is the most typical example of the latter.
The mixed subtype
The mixed subtype exhibits word comprehension defi-
cits along with speech apraxia or agrammatism, a com-
bination of positive findings that does not occur in the
current classification [6, 52] (Fig. 5). In our experience,
this mixed variant is not rare. In a consecutive series of
PPA cases at our memory clinic, 3 out of 21 are of the
mixed variant, a proportion similar to that reported by
Mesulam et al. [6] (2 out of 25). A group-based volumet-
ric analysis of mixed PPA revealed atrophy in inferior
frontal, superior temporal, and anterior temporal cortex
[6]. Among six patients with mixed variant PPA, four
had AD as underlying pathology, one had FTLD-tau,
and one had mixed pathology of AD and TDP-A [9].
Anomic-only PPA
Patients may fulfill the root criterion of PPA based on
their anomia, in the absence of any of the other features
that distinguish between subtypes, most notably normal
performance on repetition of complex sentences and on
Objective word finding deficitROOT DIAGNOSIS OF PPA
Motor speech deficit or agrammatism 
YES NO
Comprehension impaired
Phonological short-term 
memory deficit
1 .Agrammatism only 
Semantic
variant
Logopenic
variant
2. Primary progressive 
apraxia of speech
Anomic only variant
Comprehension impaired
Mixed 
variant
YES
YES
YESNO NO
NO
3. Agrammatism plus  
speech apraxia 
Nonfluent
variant
Fig. 5 Based on the literature reviewed after the 2011 recommendations, some modifications may be worth considering when describing
cohorts for research. Currently the clinical impact of these modifications is insufficiently documented to recommend this updated scheme for use
in clinical practice
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that would permit assignment to one of the three sub-
types (Fig. 5). The prevalence in a series of PPA patients
was 3 out of 25 [6]. A somewhat related subclass are
PPA-L*, who have prominent word finding problems
during spontaneous speech but have relatively preserved
confrontation naming. PPA-L* have a hesitant spontan-
eous speech but are missing the repetition deficit typical
of LV [9]. It is conceivable that these cases may develop
some of the distinguishing features later in the course of
the disease.
Towards an etiological diagnosis of PPA
The clinical utility of biomarkers such as cerebrospinal
fluid Aβ42 and amyloid PET in patients with PPA pre-
senting in a memory clinic depends on the difference be-
tween pre- and post-test odds of an etiological diagnosis
[53] and on the clinical benefit of potential changes in
patient management.
Increase in diagnostic accuracy
None of the three phenotypic subtypes entirely excludes
the possibility of AD as the underlying cause. PPA LV
has the highest positive predictive value for AD neuro-
pathology but, even so, neuropathological series show a
prevalence of AD pathology in PPA LV of only 50–60 %
[9, 26]. Inversely, PPA SV or NFV are far more oftendue to FTLD but can be caused by AD in 10–25 % of
cases [9, 26]. The prevalence of AD as the underlying
cause in the other categories, such as mixed or anomic
variant, is currently unknown. Hence, the highest yield
of biomarkers would probably be obtained in LV, anomic
or mixed-variant PPA, and in SV in an early phase.
Clinical utility
The clinical utility of an etiological diagnosis in PPA has
not been proven empirically. Conceivably, patients with
PPA due to AD may have a cholinergic deficit and hence
benefit from cholinesterase inhibitors. Prognostically, the
time course expected in patients with PPA due to AD may
differ from that in PPA due to a TDP43 proteinopathy or
a tauopathy such as CBD or PSP. For instance, the behav-
ioral manifestations may be qualitatively different in FTLD
compared with AD, with more obsessive-compulsive be-
haviors, lack of empathy, and eating abnormalities. In case
of PPA due to tauopathy, limb apraxia, gait and postural
problems, and dysphagia may impair the autonomy of the
patient earlier in the course of the disease compared with
PPA due to AD. Inversely, the cognitive domains affected
over the disease course in LV due to AD may expand into
nonverbal domains. A correct etiological diagnosis at the
initial stage may help the patient, caregiver, and physician
to anticipate specific problems which may benefit patient
management. A correct etiological diagnosis in vivo could
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ment aimed at disease modification.
Need for modification of the criteria?
Unclassified PPA
In itself the observation that a substantial proportion of
cases who fulfill the root criterion of PPA do not fall into
one of the subtypes (the anomic-only variant) is not ne-
cessarily a reason for a revision, as long as these cases
are not “forced” into one of the subtypes when commu-
nicating research findings or in clinical practice. It is im-
portant to recognize in the clinic and in research that
the three subtypes do not encompass the full spectrum
of PPA phenotypes, as described above [27]. The ques-
tion then becomes whether within the unclassifiable
cases some patterns can be discerned that merit the sta-
tus of an additional subtype (Fig. 5).
Addition of subtypes
For the purpose of communicating research findings we
believe that there is sufficient evidence and also a need
to allow for one additional denotation: the mixed sub-
type. Based on the prevalence reported, ignoring this
subtype would lead to misclassification of about 15 % of
cases in research papers on PPA. This additional subtype
constitutes an important target group for further re-
search to determine the anatomical and etiological basis
and the potential relevance for patient treatment.
Subdivision of subtypes
Within the NFV, a more fine-grained level of description
would specify the agrammatic-only variant, the speech
apraxia-only variant, and the combination of both [42].
There are two caveats: it remains to be proven that the
underlying neuropathology differs sufficiently between
these subdivisions; and such a subdivision heavily relies
on evidence that either motor speech or grammatical
processing is preserved and this critically depends on
the sensitivity of tests and the disease stage.
Within the LV it may be more accurate to distinguish
between a subgroup with more widespread language in-
volvement and broader anatomical involvement resem-
bling left hemisphere-dominant AD and a subgroup
with LV restricted to phonological working memory def-
icit and focal damage of the temporoparietal transition
zone. The more restricted form has a lower likelihood of
AD than the more widespread form.
Conclusions
Obviously, from the patient and caregiver perspective, a
revision would be justified if it has a positive impact on
the management of individual patients, as was the case,
e.g., for the LV subtype as a recognition of AD as the fre-
quent underlying cause. The 2011 recommendations hadan impact beyond research. Before a modification would
be deemed of use for clinical practice, more empirical
data would be needed regarding the impact of these
modifications on prediction of the temporal course or
neuropathology and on patient management. Clinic-
ally, in our opinion, a higher benefit will be gained
from implementing in vivo biomarkers of underlying
neuropathological lesions, such as cerebrospinal fluid
biomarkers for AD or amyloid PET [53, 54], than
from ever-increasing sophistication at the clinical-
phenotypical level.
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